137 related articles for article (PubMed ID: 3143539)
1. [Therapy of paroxysmal atrial fibrillation. Cardiac glycosides alone or combined with anti-arrhythmia agents?].
Steinbeck G; Doliwa R; Bach P
Dtsch Med Wochenschr; 1988 Dec; 113(48):1867-71. PubMed ID: 3143539
[TBL] [Abstract][Full Text] [Related]
2. [The use of digitalis glycosides in atrial fibrillation].
Knez A; Haberl R; Steinbeck G
Z Kardiol; 1994; 83 Suppl 5():71-3. PubMed ID: 7846948
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of oral propafenone versus quinidine in the treatment of recent onset atrial fibrillation: A randomized, prospective study.
Kosior DA; Kochanowski J; Scisło P; Piatkowski R; Postuła M; Rabczenko D; Opolski G
Cardiol J; 2009; 16(6):521-7. PubMed ID: 19950088
[TBL] [Abstract][Full Text] [Related]
4. The efficacy of intravenous amiodarone for the conversion of chronic atrial fibrillation. Amiodarone vs quinidine for conversion of atrial fibrillation.
Kerin NZ; Faitel K; Naini M
Arch Intern Med; 1996 Jan; 156(1):49-53. PubMed ID: 8526696
[TBL] [Abstract][Full Text] [Related]
5. Atrial fibrillation: rate control often better than rhythm control.
Prescrire Int; 2004 Apr; 13(70):64-9. PubMed ID: 15148984
[TBL] [Abstract][Full Text] [Related]
6. Prospective comparison of flecainide versus quinidine for the treatment of paroxysmal atrial fibrillation/flutter. The Flecainide Multicenter Atrial Fibrillation Study Group.
Naccarelli GV; Dorian P; Hohnloser SH; Coumel P
Am J Cardiol; 1996 Jan; 77(3):53A-59A. PubMed ID: 8607392
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: prospective comparison of sotalol versus quinidine.
Hohnloser SH; van de Loo A; Baedeker F
J Am Coll Cardiol; 1995 Oct; 26(4):852-8. PubMed ID: 7560608
[TBL] [Abstract][Full Text] [Related]
8. [A comparison between flecainide and sotalol in the prevention of recurrences of paroxysmal atrial fibrillation].
Carunchio A; Fera MS; Mazza A; Burattini M; Greco G; Galati A; Ceci V
G Ital Cardiol; 1995 Jan; 25(1):51-68. PubMed ID: 7642012
[TBL] [Abstract][Full Text] [Related]
9. Intravenous amiodarone bolus versus oral quinidine for atrial flutter and fibrillation after cardiac operations.
McAlister HF; Luke RA; Whitlock RM; Smith WM
J Thorac Cardiovasc Surg; 1990 May; 99(5):911-8. PubMed ID: 2184287
[TBL] [Abstract][Full Text] [Related]
10. Is newer better? Propafenone versus quinidine for conversion of atrial fibrillation.
Daubert JP
Cardiol J; 2009; 16(6):491-2. PubMed ID: 19950083
[No Abstract] [Full Text] [Related]
11. [Combination of quinidine and verapamil in auricular fibrillation].
Sobrino JA; Maté I; Calvo L; Plaza I; Rico J; Moreno I; Mesa JM
Rev Esp Cardiol; 1989 Apr; 42(4):262-6. PubMed ID: 2781120
[TBL] [Abstract][Full Text] [Related]
12. Long-term results of hybrid therapy in patients with atrial fibrillation who develop atrial flutter during flecainide infusion.
Turco P; De Simone A; La Rocca V; El Jamal B; Nocerino P; Astarita C; De Matteis C; Messina V; Greco L; Rotunno R; Di Napoli T; Vitale DF; Stabile G
Pacing Clin Electrophysiol; 2005 Jan; 28 Suppl 1():S124-7. PubMed ID: 15683478
[TBL] [Abstract][Full Text] [Related]
13. [Amiodarone and verapamil/quinidine in treatment of patients with chronic atrial fibrillation].
Zehender M; Meinertz T; Just H
Z Kardiol; 1994; 83 Suppl 5():101-8. PubMed ID: 7846938
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacologic restoration of sinus rhythm in atrial flutter and fibrillation].
Vainer J; Smíd J; Cepeláková H; Hapala J; Topinka I; Topolcan O
Vnitr Lek; 1989 Feb; 35(2):145-50. PubMed ID: 2711622
[TBL] [Abstract][Full Text] [Related]
15. [The role of an electropharmacological transesophageal test in the prevention of paroxysmal atrial fibrillation. Experience with flecainide].
De Sisti A; Matteucci C; Patrissi T; Accogli S; Di Lorenzo M; Sasdelli M; Ciolli A; Lo Sardo G; Palamara A
G Ital Cardiol; 1998 Dec; 28(12):1391-9. PubMed ID: 9887393
[TBL] [Abstract][Full Text] [Related]
16. Flecainide versus quinidine in the prevention of paroxysms of atrial fibrillation.
van Wijk LM; den Heijer P; Crijns HJ; van Gilst WH; Lie KI
J Cardiovasc Pharmacol; 1989 Jan; 13(1):32-6. PubMed ID: 2468933
[TBL] [Abstract][Full Text] [Related]
17. A prospective, randomized controlled trial comparing the efficacy and safety of sotalol, amiodarone, and digoxin for the reversion of new-onset atrial fibrillation.
Joseph AP; Ward MR
Ann Emerg Med; 2000 Jul; 36(1):1-9. PubMed ID: 10874228
[TBL] [Abstract][Full Text] [Related]
18. Digoxin -- quinidine interaction.
Reid PR; Meek AG
Johns Hopkins Med J; 1979 Dec; 145(6):227-9. PubMed ID: 513429
[TBL] [Abstract][Full Text] [Related]
19. Prospective randomized study comparing amiodarone vs. amiodarone plus losartan vs. amiodarone plus perindopril for the prevention of atrial fibrillation recurrence in patients with lone paroxysmal atrial fibrillation.
Yin Y; Dalal D; Liu Z; Wu J; Liu D; Lan X; Dai Y; Su L; Ling Z; She Q; Luo K; Woo K; Dong J
Eur Heart J; 2006 Aug; 27(15):1841-6. PubMed ID: 16825288
[TBL] [Abstract][Full Text] [Related]
20. [Effects of intravenous flecainide in the treatment of paroxysmal or recent-onset atrial fibrillations].
Bolognesi R; Tsialtas D; Manca C; Visioli O
Cardiologia; 1989 Feb; 34(2):173-6. PubMed ID: 2500238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
